{"id":"NCT00929110","sponsor":"Novartis","briefTitle":"1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)","officialTitle":"A 52-week Treatment, Randomized, Double-blind, Placebo-controlled, With Open-label Tiotropium, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Patients With Chronic Obstructive Pulmonary Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-06","primaryCompletion":"2011-04","completion":"2011-04","firstPosted":"2009-06-26","resultsPosted":"2012-07-27","lastUpdate":"2012-08-17"},"enrollment":1066,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease"],"interventions":[{"type":"DRUG","name":"Glycopyrronium bromide","otherNames":["NVA237"]},{"type":"DRUG","name":"Placebo to glycopyrronium bromide","otherNames":[]},{"type":"DRUG","name":"Tiotropium","otherNames":[]}],"arms":[{"label":"Glycopyrronium bromide 50 μg","type":"EXPERIMENTAL"},{"label":"Placebo to glycopyrronium bromide","type":"PLACEBO_COMPARATOR"},{"label":"Tiotropium 18 μg","type":"ACTIVE_COMPARATOR"}],"summary":"This study was designed to investigate the 1 year efficacy and safety of the 50 µg once daily (od) dose of glycopyrronium bromide (NVA237) in patients with moderate to severe chronic obstructive pulmonary disease.","primaryOutcome":{"measure":"Trough Forced Expiratory Volume in 1 Second (FEV1) at Week 12","timeFrame":"Week 12","effectByArm":[{"arm":"Glycopyrronium Bromide 50 μg","deltaMin":1.469,"sd":0.0141},{"arm":"Placebo to Glycopyrronium Bromide","deltaMin":1.372,"sd":0.0173},{"arm":"Tiotropium 18 μg","deltaMin":1.455,"sd":0.017}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":139,"countries":["United States","Argentina","Canada","Chile","France","Germany","Hungary","Israel","Italy","Mexico","Netherlands","New Zealand","Peru","Poland","Russia","South Korea"]},"refs":{"pmids":["24156566","23060624"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":65,"n":525},"commonTop":["Chronic obstructive pulmonary disease","Upper respiratory tract infection","Nasopharyngitis","Upper respiratory tract infection bacterial","Sinusitis"]}}